{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:26:00Z","timestamp":1782368760113,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.diagmicrobio.2020.115098","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T20:18:59Z","timestamp":1591042739000},"page":"115098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant"],"prefix":"10.1016","volume":"98","author":[{"given":"Selay","family":"Demirci-Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Unalan-Altintop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgen Koseoglu","family":"Eser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131","family":"Cakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belgin","family":"Altun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Sancak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0005","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3201\/eid2111.150750","article-title":"Fosfomycin resistance in Escherichia coli, Pennsylvania, USA","volume":"21","author":"Alrowais","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0010","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.01604-13","article-title":"Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-\u03b2-lactamase-positive and-negative E. coli clinical isolates from the Chicago region, 2007 to 2010","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5578\/mb.10695","article-title":"T\u00fcrkiye'de 2014 yili i\u00e7inde izole edilen karbapeneme diren\u00e7li Escherichia coli ve Klebsiella pneumoniae izolatlarinda karbapenemaz varliginin arastirilmasi","author":"\u00c7akar","year":"2016","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fmicb.2018.00243","article-title":"Comprehensive molecular characterization of Escherichia coli isolates from urine samples of hospitalized patients in Rio de Janeiro, Brazil","volume":"9","author":"Campos","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"Can","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jgar.2015.10.006","article-title":"The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli","volume":"4","author":"Can","year":"2016","journal-title":"Journal of global antimicrobial resistance"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S0950268816002879","article-title":"High prevalence of fosfomycin resistance gene fosA3 in Bla CTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010\u20132014","volume":"145","author":"Cao","year":"2017","journal-title":"Epidemiology & Infection"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0040","first-page":"13","article-title":"Investigation of high-risk ST131 clone in ESBL-producing Escherichia coli isolates isolated from urine and non-urinary clinical specimens with MALDI-TOF MS and real time PCR","volume":"52","author":"Cizmeci","year":"2018","journal-title":"Mikrobiyoloji bulteni"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jac\/dkp194","article-title":"Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains","volume":"64","author":"Clermont","year":"2009","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0050","first-page":"9","article-title":"Investigating antifungal susceptibility in candida species with maldi-tof ms-based assays","author":"Delavy","year":"2019","journal-title":"Frontiers in cellular and infection microbiology"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics6040024","article-title":"Fosfomycin: pharmacological, clinical and future perspectives","volume":"6","author":"Dijkmans","year":"2017","journal-title":"Antibiotics"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0200","unstructured":"EUCAST. The European Committee on Antimicrobial Susceptibility Testing. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Resistance_mechanisms\/EUCAST_detection_of_resistance_mechanisms_v1.0_20131211.pdf. 2018. Breakpoint tables for interpretation of MICs and zone diameters, version 8.0. http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 10\/1\/2018."},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12894-017-0222-6","article-title":"The susceptibility to fosfomycin of gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study","volume":"17","author":"Fajfr","year":"2017","journal-title":"BMC Urol"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0070","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1021\/ja039307z","article-title":"Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms","volume":"125","author":"Fillgrove","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tim.2018.01.007","article-title":"Dynamic fungal cell wall architecture in stress adaptation and immune evasion","volume":"26","author":"Hopke","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0080","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2018.3627","article-title":"Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial","volume":"319","author":"Huttner","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40121-017-0150-5","article-title":"Fosfomycin and comparator activity against select Enterobacteriaceae, Pseudomonas, and Enterococcus urinary tract infection isolates from the United States in 2012","volume":"6","author":"Keepers","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0090","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1021\/bi952937w","article-title":"Characterization of a Cys115 to asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin","volume":"35","author":"Kim","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0095","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/AAC.00171-08","article-title":"Molecular characterization and epidemiology of extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic","volume":"52","author":"Kiratisin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diagmicrobio.2006.11.015","article-title":"In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli isolated from urine and blood","volume":"58","author":"Ko","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0105","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/jac\/dks319","article-title":"Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS 26-composite transposon surrounding fosA3","volume":"67","author":"Lee","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0110","article-title":"Antimicrobial susceptibility and molecular mechanisms of fosfomycin resistance in clinical Escherichia coli isolates in mainland China","volume":"10","author":"Li","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3201\/eid2202.151301","article-title":"Importation of fosfomycin resistance fosA3 gene to Europe","volume":"22","author":"Mendes","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkm464","article-title":"Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15","volume":"61","author":"Nicolas-Chanoine","year":"2008","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0130","unstructured":"Nigiz \u015e, Haz\u0131rolan G, Eser \u00d6, G\u00fcr D. Investigation of fosfomycin resistance mechanisms in Escherichia coli and Klebsiella spp. urinary tract isolates; The First fosA3 gene isolated in Turkey. 5th National Clinical Microbiology Congress. 28 October-1 November 2019; Tepekule Convention and Exhibition Center. Bayrakl\u0131, \u0130zmir. Oral presentation-46"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0135","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms of fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0140","article-title":"Drug and vaccine development for the treatment and prevention of urinary tract infections","volume":"4","author":"O'Brien","year":"2016","journal-title":"Microbiology spectrum"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0145","doi-asserted-by":"crossref","unstructured":"Ohkoshi Y, Sato T, Suzuki Y, Yamamoto S, Shiraishi T, Ogasawara N, Yokota S-i. 2017. Mechanism of reduced susceptibility to fosfomycin in Escherichia coli clinical isolates. BioMed research international 2017.","DOI":"10.1155\/2017\/5470241"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0150","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0b013e3182863a1c","article-title":"Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis","volume":"32","author":"Pammi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","article-title":"Molecular epidemiology of Escherichia coli producing CTX-M \u03b2-lactamases: the worldwide emergence of clone ST131 O25: H4","volume":"35","author":"Peirano","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0160","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/AAC.01763-10","article-title":"Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131","volume":"55","author":"Peirano","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0165","doi-asserted-by":"crossref","unstructured":"Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M. 2013. The epidemic of extended-spectrum-\u03b2-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 4:e00377\u201313.","DOI":"10.1128\/mBio.00377-13"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0170","first-page":"43","article-title":"Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)","volume":"26","author":"Rodriguez-Avial","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0180","doi-asserted-by":"crossref","unstructured":"Sardar A, Basireddy SR, Navaz A, Singh M, Kabra V. 2017. Comparative evaluation of fosfomycin activity with other antimicrobial agents against E. coli isolates from urinary tract infections. Journal of clinical and diagnostic research: JCDR 11:DC26.","DOI":"10.7860\/JCDR\/2017\/23644.9440"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/mdr.2013.0061","article-title":"First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan","volume":"19","author":"Sato","year":"2013","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0190","doi-asserted-by":"crossref","first-page":"a025262","DOI":"10.1101\/cshperspect.a025262","article-title":"Fosfomycin: mechanism and resistance","volume":"7","author":"Silver","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.diagmicrobio.2020.115098_bb0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/ciy523","article-title":"The uropathogenic Escherichia coli subclone sequence type 131-H 30 is responsible for most antibiotic prescription errors at an urgent care clinic","volume":"68","author":"Tchesnokova","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320304752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320304752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:39Z","timestamp":1760003619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889320304752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0732889320304752"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115098","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115098"}}